Sign in to view content

Three-Year Outcomes of the PALADIN Phase IV Study: Comparison of Anatomical Metrics, Efficacy, and Treatment Burden Post FAc

Christopher D. Riemann, MD

Video
Published 2022

Related

What Happens to Diabetic Retinopathy Severity Scores With Less Aggressive Treatment? A Post Hoc Analysis of the RISE and RIDE Open Label Extension Study
Roger A. Goldberg, MD, MBA
Annual Meeting Talks
2019
Randomized Trial of Initiating Therapy With Aflibercept, Laser, or Observation for Eyes With Good Vision and Center-Involved DME
Carl W. Baker, MD, FASRS
Annual Meeting Talks
2019
ASRS Updates in the Management of Diabetic Retinopathy DME and PDR in the Middle East and Africa
Sunir J. Garg, MD, FACS, FASRS
Webinars and Journal Clubs
2023

Category: Diabetic Retinopathy

See more